Tridem Bioscience FlexCo — Biomedical Watch V2

Traitements3programmes

Essais2liés

Publications0liées

SourceDBlocale

Traitements

3

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
TRB-001An unblinded, single arm, pilot observational study to test the safety, tolerability, immunogenicity and the biological effects of TRB-001 vaccination in individuals who have previously undergone aSyn immunotherapy	Parkinson	Phase 1	À vérifier	Austria	À vérifier
TRB-001An unblinded, single arm, pilot observational study to test the safety, tolerability, immunogenicity and the biological effects of TRB-001 vaccination in individuals who have previously undergone aSyn immunotherapy	Parkinson	Phase 1	À vérifier	Austria	À vérifier
TRB-001An unblinded, single arm, pilot observational study to test the safety, tolerability, immunogenicity and the biological effects of TRB-001 vaccination in individuals who have previously undergone aSyn immunotherapy	Parkinson	Phase 1	À vérifier	Austria	À vérifier

Essais cliniques

2

Molécule	Indication / population	Phase	NCT	Titre	Statut
TRB-001	Parkinson	Phase 1	NCT07840027	Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease	RECRUITING
TRB-001	Parkinson	Phase 1	NCT07777484	An Unblinded, Single Arm, Pilot Observational Study to Test the Safety, Tolerability, Immunogenicity and the Biological Effects of TRB-001 Vaccination.	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.